SISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend

Bulletin Express

Mar 06

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.

According to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1129289640"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129289640\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129289640?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129289640","market":"us","top_or_hot":-1,"title":"SISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend","media":"Bulletin Express","content":"<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.</p>\n<p>According to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-06 17:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.</p>\n<p>According to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01696","symbol_name":"复锐医疗科技","start_time":0,"source_url":"","article_id":"1129289640","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129289640","pubTimestamp":1772789065,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01696":"复锐医疗科技"},"translate_title":"SISRAM MED(01696)安排董事会会议讨论2025年年度业绩和股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01696":1},"content_text":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.\nAccording to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}